Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells

Details for Australian Patent Application No. 2002319050 (hide)

Owner Nymox Corporation

Inventors Gemmell, Jack; Averback, Paul A.

Agent FB Rice

Pub. Number AU-B-2002319050

PCT Number PCT/CA02/01106

PCT Pub. Number WO2003/008444

Priority 60/306,150 19.07.01 US; 60/306,161 19.07.01 US; 60/331,477 16.11.01 US

Filing date 19 July 2002

Wipo publication date 3 March 2003

Acceptance publication date 11 September 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61K 47/46 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Ingredients of undetermined constitution or reaction products thereof

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/02 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 3/02 (2006.01) Drugs for disorders of the metabolism

A61P 5/00 (2006.01) Drugs for disorders of the endocrine system

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 13/10 (2006.01) Drugs for disorders of the urinary system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 17/04 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 17/12 (2006.01) Drugs for dermatological disorders

A61P 17/14 (2006.01) Drugs for dermatological disorders

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/306,150 19.07.01 US; 60/306,161 19.07.01 US; 60/331,477 16.11.01 US

22 May 2003 Application Open to Public Inspection

  Published as AU-B-2002319050

11 September 2008 Application Accepted

  Published as AU-B-2002319050

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002319051-METAL-CORED BIPOLAR SEPARATOR AND END PLATES FOR POLYMER ELECTROLYTE MEMBRANE ELECTROCHEMICAL AND FUEL CELLS

2002319049-Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells